drugset / Trial / NCT00689247

To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305

NCT00689247

Phase 1 Completed 10 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to learn more about how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion of AZD1305.

Timeline

Start
2008-04
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1305 Small molecule Oral

Indications

No indication recorded.